21.4 C
New York
Thursday, June 4, 2026

Tag: valves

First Reserve-Backed Trillium Flow Technologies Announces Sale of French Valves Operations to Framatome

STAMFORD, Conn. and HOUSTON, June 2, 2026 /PRNewswire/ -- Trillium Flow Technologies ("Trillium"), a portfolio company of First Reserve and a leading provider of...

Anteris Announces Results for the Second Quarter of 2025

Anteris Announces Results for the Second Quarter of 2025

All-new 2026 Dodge Charger Scat Pack Drops the Hammer With 550 Horsepower, AWD Fury and Gasoline-powered Old-school Attitude as Most Powerful Car Under $55,000

AUBURN HILLS, Mich., Aug. 8, 2025 /PRNewswire/ -- 2026 Dodge Charger Scat Pack, powered by the turbocharged SIXPACK high-output (H.O.) engine, clocks a 3.9-second 0-60 time...

Services PMI® at 50.1%; July 2025 Services ISM® Report On Business®

Business Activity Index at 52.6%; New Orders Index at 50.3%; Employment Index at 46.4%; Supplier Deliveries Index at 51% TEMPE, Ariz., Aug. 5, 2025 /PRNewswire/ --...

Endocarditis Market Global and Regional Research Report 2025-2035 | AI and Molecular Diagnostics Set to Revolutionize Endocarditis Management

Endocarditis, a heart infection caused by bacteria in the bloodstream, is experiencing growing incidence due to rising healthcare-associated infections, intravenous drug use, and aging populations with prosthetic valves. Advances in diagnostic imaging, AI-assisted echocardiography, and minimally invasive cardiac procedures are improving detection and patient outcomes. However, challenges like early detection difficulties and antimicrobial resistance persist. North America leads in the endocarditis market, with significant growth seen in the Asia-Pacific due to increased cardiovascular cases and healthcare investments. Key players like Pfizer and Teva Pharmaceutical are driving innovations in the sector.
Endocarditis, a heart infection caused by bacteria in the bloodstream, is experiencing growing incidence due to rising healthcare-associated infections, intravenous drug use, and aging populations with prosthetic valves. Advances in diagnostic imaging, AI-assisted echocardiography, and minimally invasive cardiac procedures are improving detection and patient outcomes. However, challenges like early detection difficulties and antimicrobial resistance persist. North America leads in the endocarditis market, with significant growth seen in the Asia-Pacific due to increased cardiovascular cases and healthcare investments. Key players like Pfizer and Teva Pharmaceutical are driving innovations in the sector.

Mueller Water Products Reports 2025 Third Quarter Results

Increased Net Sales 6.6% to $380.3 Million

Mueller Water Products Releases 2024 ESG Report

Report Highlights Several Key Achievements
Report Highlights Several Key Achievements

Jewellok Unveils Cutting-Edge Specialty Gas Changeover Manifolds to Revolutionize Industrial and Medical Gas Delivery

Jewellok is a specialty gas automatic changeover manifold manufacturer and supplier, manufacturing semi-automatic and automatic stainless steel high-purity oxygen, nitrogen, helium, and argon gas...

Mueller Water Products Announces Quarterly Dividend

ATLANTA, July 30, 2025 (GLOBE NEWSWIRE) -- Mueller Water Products, Inc. (NYSE: MWA) announced that its Board of Directors has declared a quarterly dividend of $0.067 per share, payable on or about August 21, 2025, to stockholders of record as of the close of business on August 12, 2025.

Artivion to Participate in Upcoming Investor Conferences

ATLANTA, July 30, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it...

Standard Motor Products Expands Turbocharger Program

Key Takeaways The Standard® Turbocharger program features complete, all-new, no-core Turbocharger Kits for gas and diesel vehiclesStandard® Turbocharger Kits include all of the related parts...

Mueller Water Products Announces Dates for Third Quarter 2025 Earnings Release and Conference Call

ATLANTA, July 22, 2025 (GLOBE NEWSWIRE) -- Mueller Water Products, Inc. (NYSE: MWA) plans to release financial results for its third quarter ended June 30, 2025, after U.S. markets close on Monday, August 4, 2025. On Tuesday, August 5, 2025, at 10:00 a.m. ET, the Company will hold a conference call to discuss earnings and business results. Interested parties are invited to listen via webcast available on the Investor Relations section of the Company’s website www.muellerwaterproducts.com. An archive of the webcast will be available for approximately 90 days following the call.

Pacuzzi Releases 2025 Pacuzzi Skillet Steamer Innovation Amid Surging Demand for Multi-Use Cookware

This release explores how Pacuzzi’s 2025 cookware model delivers on the rising need for modular, space-saving tools that support healthier cooking and efficient kitchens.
This release explores how Pacuzzi’s 2025 cookware model delivers on the rising need for modular, space-saving tools that support healthier cooking and efficient kitchens.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsValves